-+ 0.00%
-+ 0.00%
-+ 0.00%

Modern Chinese Medicine expects RMB 25.9 million H1 net loss vs RMB 2.5 million profit a year earlier

PUBT·08/21/2026 12:06:49
Listen to the news
Modern Chinese Medicine expects RMB 25.9 million H1 net loss vs RMB 2.5 million profit a year earlier
  • Modern Chinese Medicine Group expects a net loss of about RMB 25.9 million for the six months ended June 30, 2026.
  • That compares with a net profit of about RMB 2.5 million in the prior-year period.
  • Higher promotion and marketing spending tied to expansion in eastern China weighed on results.
  • Rising R&D costs, including enhanced clinical value research to improve product quality, also pressured earnings.
  • Interim results are scheduled for publication on Aug. 28, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Modern Chinese Medicine Group Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260821-12294778), on August 21, 2026, and is solely responsible for the information contained therein.